Institutional Ownership Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT). We have compiled data on the 166 institutions that hold shares in the stock, with a total of 71.6 Million shares, which have been reported (via 13F filing form) to have a value of $737 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2025 Q1 2025 |
8,325,000
shares
|
$87.7 Million
4.79% of portfolio
|
Q2 2024
Added 20.77%
|
|
|
Suvretta Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
6,804,091
shares
|
$71.7 Million
1.61% of portfolio
|
Q1 2025
Added 0.31%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
6,200,000
shares
|
$65.3 Million
0.07% of portfolio
|
Q1 2025
Added 7.83%
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
4,149,861
shares
|
$43.7 Million
0.01% of portfolio
|
Q1 2025
Added 0.3%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 08, 2025 Q1 2025 |
4,085,580
shares
|
$43.1 Million
0.05% of portfolio
|
Q1 2025
Added 10.2%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,834,368
shares
|
$40.4 Million
0.0% of portfolio
|
Q1 2025
Added 0.82%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,764,881
shares
|
$39.7 Million
0.0% of portfolio
|
Q2 2024
Added 35.07%
|
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
May 14, 2025 Q1 2025 |
3,572,335
shares
|
$37.7 Million
4.66% of portfolio
|
Q4 2024
Added 287.31%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
May 15, 2025 Q1 2025 |
3,181,818
shares
|
$33.5 Million
0.36% of portfolio
|
Q4 2024
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
2,286,089
shares
|
$24.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.33%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
1,593,211
shares
|
$16.8 Million
0.0% of portfolio
|
Q1 2025
Added 6.81%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,593,030
shares
|
$16.8 Million
0.0% of portfolio
|
Q1 2025
Added 3.52%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
1,537,274
shares
|
$16.2 Million
0.35% of portfolio
|
Q4 2024
Added 48.2%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
1,531,556
shares
|
$16.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 7.87%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
May 14, 2025 Q1 2025 |
1,481,977
shares
|
$15.6 Million
3.32% of portfolio
|
Q1 2025
Added 5.08%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
1,354,014
shares
|
$14.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 36.87%
|
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
May 13, 2025 Q1 2025 |
1,169,857
shares
|
$12.3 Million
1.83% of portfolio
|
Q4 2024
Reduced 24.6%
|
|
|
Finepoint Capital LP
Boston, MA |
May 14, 2025 Q1 2025 |
1,081,954
shares
|
$11.4 Million
0.62% of portfolio
|
Q1 2025
Reduced 2.62%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,050,000
shares
|
$11.1 Million
3.94% of portfolio
|
Q3 2024
Added 2000.0%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
864,111
shares
|
$9.11 Million
0.0% of portfolio
|
Q1 2025
Added 15.93%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
May 15, 2025 Q1 2025 |
797,594
shares
|
$8.41 Million
2.23% of portfolio
|
Q1 2025
Added 19.47%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
750,212
shares
|
$7.91 Million
0.0% of portfolio
|
Q1 2025
Added 15.77%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
629,879
shares
|
$6.64 Million
0.0% of portfolio
|
Q1 2025
Reduced 2.06%
|
|
|
Hsbc Holdings PLC
London, X0 |
May 14, 2025 Q1 2025 |
625,140
shares
|
$6.59 Million
0.0% of portfolio
|
Q1 2025
Added 142.66%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
May 15, 2025 Q1 2025 |
593,091
shares
|
$6.25 Million
0.14% of portfolio
|
Q1 2025
Reduced 1.15%
|